Article
Immunotherapy for gastric cancer: dilemmas and prospect
16 Oct 2018
Abstract excerpt
Gastric cancer remains the second most common cause of cancer-related death worldwide. Because of the poor prognosis of late-stage gastric cancer patients, it is imperative to develop new strategies to improve the survival rate of this disease. Currently, immunotherapy is considered as an innovative approach for cancers such as lung cancer, gastric cancer and breast cancer. In fact, previous works have revealed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
